[go: up one dir, main page]

ES2154627T3 - Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica. - Google Patents

Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica.

Info

Publication number
ES2154627T3
ES2154627T3 ES89113852T ES89113852T ES2154627T3 ES 2154627 T3 ES2154627 T3 ES 2154627T3 ES 89113852 T ES89113852 T ES 89113852T ES 89113852 T ES89113852 T ES 89113852T ES 2154627 T3 ES2154627 T3 ES 2154627T3
Authority
ES
Spain
Prior art keywords
cisteine
somatotropins
modification
amino acids
mutagenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89113852T
Other languages
English (en)
Inventor
Susan Mancini Cady
John Steele Logan
Brian Lee Buckwalter
Gerald W Stockton
Deborah Tardy Chaleff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2154627T3 publication Critical patent/ES2154627T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENCION ES RELATIVA A NUEVAS MODIFICACIONES O RECOMBINACIONES DERIVADAS DE SOMATOTROPINAS ANIMALES. ESTA INVENCION TAMBIEN PROVEE METODOS PARA ESTABILIZAR RECOMBINACIONES DE SOMATOTROPINAS ANIMALES POR MODIFICACION O SUPRESION DE LA CISTEINA SOBRANTE USANDO MUTACION GENETICA PARA REEMPLAZAR DE UNO A CUATRO DE LOS AMINO ACIDOS DE CISTEINA SOBRANTES DE DICHAS SOMATOTROPINAS CON UNO O MAS AMINO ACIDOS DIFERENTES SOBRANTES O POR DERIVACION DE (1) AMBOS AMINO ACIDOS DE CISTEINA SOBRANTE EN EL ANILLO PEQUEÑO DE DICHA SOMATOTROPINA, AMBOS AMINO ACIDOS DE CISTEINA SOBRANTE EN EL ANILLO GRANDE O LOS CUATRO AMINO ACIDOS SOBRANTES EN AMBOS ANILLOS DE DICHA SOMATOTROPINA.
ES89113852T 1988-08-24 1989-07-27 Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica. Expired - Lifetime ES2154627T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23606088A 1988-08-24 1988-08-24
US37269989A 1989-07-03 1989-07-03

Publications (1)

Publication Number Publication Date
ES2154627T3 true ES2154627T3 (es) 2001-04-16

Family

ID=26929421

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89113852T Expired - Lifetime ES2154627T3 (es) 1988-08-24 1989-07-27 Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica.

Country Status (18)

Country Link
US (1) US5891840A (es)
EP (1) EP0355460B1 (es)
JP (1) JP2894355B2 (es)
AR (1) AR245138A1 (es)
AT (1) ATE198353T1 (es)
AU (1) AU630105B2 (es)
DE (1) DE68929273T2 (es)
DK (1) DK416589A (es)
ES (1) ES2154627T3 (es)
FI (1) FI104908B (es)
GR (1) GR3035608T3 (es)
HU (1) HU217095B (es)
IE (1) IE892706A1 (es)
IL (1) IL91156A (es)
NO (1) NO893387L (es)
NZ (1) NZ230342A (es)
PT (1) PT91512B (es)
YU (1) YU163289A (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2580303B2 (ja) * 1987-02-19 1997-02-12 ジ・アップジョン・カンパニー 異種蛋白をコ−ド付けするｃＤＮＡ類、発現ベクタ−類および宿主類
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5951972A (en) * 1990-05-04 1999-09-14 American Cyanamid Company Stabilization of somatotropins and other proteins by modification of cysteine residues
ATE163431T1 (de) * 1990-05-04 1998-03-15 American Cyanamid Co Stabilisierung von somatotropin durch modifizierung von cysteinsresten
DK168790D0 (es) * 1990-07-13 1990-07-13 Novo Nordisk As
US6894023B1 (en) 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
US5310882A (en) * 1990-11-30 1994-05-10 American Cyanamid Company Somatotropins with alterations in the α-helix 3 region
NZ260103A (en) * 1990-11-30 1996-10-28 Bio Technology General Corp Somatotropin with alterations in the alpha-helix-1 region
GB9100381D0 (en) * 1991-01-09 1991-02-20 Erba Carlo Spa Human bfgf derivatives,their analogs and process for their production
FR2671554A1 (fr) * 1991-01-11 1992-07-17 Clonatec Sa Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.
AU654563B2 (en) * 1991-07-24 1994-11-10 Imperial Chemical Industries Plc Proteins
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7270809B2 (en) 1997-07-14 2007-09-18 Bolder Biotechnology, Inc. Cysteine variants of alpha interferon-2
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
CN1269805A (zh) 1997-07-14 2000-10-11 博尔德生物技术公司 生长激素和相关蛋白的衍生物
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
CA2408851C (en) 2000-05-16 2011-07-12 Bolder Biotechnology, Inc. Methods for refolding proteins containing free cysteine residues
US6878861B2 (en) 2000-07-21 2005-04-12 Washington State University Research Foundation Acyl coenzyme A thioesterases
US7060442B2 (en) 2000-10-30 2006-06-13 Regents Of The University Of Michigan Modulators on Nod2 signaling
WO2004022593A2 (en) * 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US8329866B2 (en) 2005-10-03 2012-12-11 Bolder Biotechnology, Inc. Long acting VEGF inhibitors and methods of use
WO2007044382A2 (en) 2005-10-07 2007-04-19 Health Protection Agency Proteins with improved solubility and methods for producing and using same
EP2102355B1 (en) 2006-12-14 2016-03-02 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
BRPI0917000A2 (pt) * 2008-08-06 2016-02-16 Novo Nordisk Healthcare Ag proteínas conjugadas com eficácia in vivo prolongada
JP5816097B2 (ja) 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
CN105963710A (zh) 2009-08-06 2016-09-28 诺沃—诺迪斯克保健股份有限公司 具有延长的体内功效的生长激素
EP2805964A1 (en) * 2009-12-21 2014-11-26 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
MX2012006980A (es) * 2009-12-21 2012-07-17 Ambrx Inc Polipeptidos de somatotropina porcina modificados y sus usos.
AU2011208620B2 (en) 2010-01-22 2015-04-16 Novo Nordisk Health Care Ag Stable growth hormone compounds
CN118767116A (zh) 2010-01-22 2024-10-15 诺沃—诺迪斯克保健股份有限公司 体内功效延长的生长激素
TR201910573T4 (tr) * 2012-08-31 2019-08-21 Glaxosmithkline Biologicals Sa Staphylococcus aureus'a karşı bağışıklık kazandırmak için stabilize edilmiş proteinler.
EP2981282B1 (en) 2013-04-05 2020-11-04 Novo Nordisk Health Care AG Growth hormone compound formulation
KR20180003677A (ko) * 2016-06-30 2018-01-10 주식회사 크레아플래닛 인간 성장호르몬 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
KR910700264A (ko) * 1989-01-19 1991-03-14 로버트 에이. 아미테이지 소마토트로핀 유사물
EP0456642A1 (en) * 1989-01-31 1991-11-21 The Upjohn Company Somatotropin analogs
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
AU4020289A (en) 1990-03-15
HUT51331A (en) 1990-04-28
EP0355460A2 (en) 1990-02-28
HU217095B (hu) 1999-11-29
NO893387D0 (no) 1989-08-23
YU163289A (en) 1992-05-28
DE68929273D1 (de) 2001-02-01
EP0355460B1 (en) 2000-12-27
JPH034797A (ja) 1991-01-10
IE892706A1 (en) 1991-01-16
IE892706L (en) 1990-02-24
FI893963A (fi) 1990-02-25
DK416589D0 (da) 1989-08-23
PT91512B (pt) 1995-05-31
PT91512A (pt) 1990-03-08
NZ230342A (en) 1992-08-26
NO893387L (no) 1990-02-26
DE68929273T2 (de) 2001-07-05
FI893963A0 (fi) 1989-08-23
AR245138A1 (es) 1993-12-30
US5891840A (en) 1999-04-06
EP0355460A3 (en) 1991-04-03
IL91156A (en) 1995-05-26
DK416589A (da) 1990-02-25
FI104908B (fi) 2000-04-28
IL91156A0 (en) 1990-03-19
AU630105B2 (en) 1992-10-22
JP2894355B2 (ja) 1999-05-24
ATE198353T1 (de) 2001-01-15
GR3035608T3 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
ES2154627T3 (es) Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica.
ATE268783T1 (de) Expression in der selben zelle von polypeptide vom schweinen reproduktiven und respiratorischen syndrom
DE69532996D1 (de) Peptidanaloge des menschlichen basischen myelinproteins
DK366889A (da) Peptidderivat
ATE273997T1 (de) Zyklische hexapeptid somatostatin analoga
PT87536A (pt) Process for the preparation of cyclic anticoagulant peptides
PT87537A (pt) Process for the preparation of cyclic anticoagulant peptides
DE69012901D1 (de) Hämoregulierende Peptide.
ES2058518T3 (es) 2-amino-1,2,3,4-tetrahidronaftalenos sustituidos en el anillo.
ES2056753A6 (es) Un procedimiento para la produccion de un polipeptido que tiene actividad de factor quemotactico de monocitos humanos.
ATE165369T1 (de) Antikoagulierende peptide
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
DK614489D0 (da) Peptidderivater
ATE98963T1 (de) Somatotropinanaloge.
DE69534596D1 (de) Epil/plazentin
MX9206732A (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas de tierra.
DE69028396D1 (de) Acetylierte heterologe polypeptide

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 355460

Country of ref document: ES